Carlo Porcellati

12.4k total citations · 3 hit papers
90 papers, 9.5k citations indexed

About

Carlo Porcellati is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Carlo Porcellati has authored 90 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cardiology and Cardiovascular Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Carlo Porcellati's work include Blood Pressure and Hypertension Studies (69 papers), Heart Rate Variability and Autonomic Control (25 papers) and Cardiovascular Function and Risk Factors (20 papers). Carlo Porcellati is often cited by papers focused on Blood Pressure and Hypertension Studies (69 papers), Heart Rate Variability and Autonomic Control (25 papers) and Cardiovascular Function and Risk Factors (20 papers). Carlo Porcellati collaborates with scholars based in Italy, United States and Belgium. Carlo Porcellati's co-authors include Giuseppe Schillaci, Paolo Verdecchia, Claudia Borgioni, Gianpaolo Reboldi, Antonella Ciucci, Ivano Zampi, M Guerrieri, Roberto Gattobigio, C Gatteschi and Francesca Boldrini and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Carlo Porcellati

89 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.

1994 1.4k citations P. Verdecchia, Carlo Porcellati et al. profile →
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.

1990 988 citations Paolo Verdecchia, Giuseppe Schillaci et al. profile →
Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension

1998 520 citations Paolo Verdecchia, Giuseppe Schillaci et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlo Porcellati Italy	41	7.9k	1.6k	1.6k	815	783	90	9.5k
Enrico Agabiti‐Rosei Italy	46	5.5k 0.7×	1.7k 1.1×	2.3k 1.5×	700 0.9×	555 0.7×	221	8.3k
Björn Dahlöf Sweden	41	8.6k 1.1×	1.5k 0.9×	3.0k 2.0×	860 1.1×	962 1.2×	94	10.7k
Vasilios Papademetriou United States	54	7.2k 0.9×	1.8k 1.2×	2.5k 1.6×	665 0.8×	689 0.9×	300	10.4k
Andrzej Rynkiewicz Poland	24	5.7k 0.7×	1.4k 0.9×	1.7k 1.1×	473 0.6×	450 0.6×	140	7.9k
Per Omvik Norway	27	6.8k 0.9×	1.1k 0.7×	3.1k 2.0×	360 0.4×	958 1.2×	125	8.7k
Cesare Cuspidi Italy	51	8.4k 1.1×	1.6k 1.0×	1.5k 1.0×	1.4k 1.7×	455 0.6×	478	10.6k
Giuseppe Germanò Italy	19	5.3k 0.7×	1.1k 0.7×	1.6k 1.0×	374 0.5×	488 0.6×	71	7.3k
Junichiro Hashimoto Japan	48	7.0k 0.9×	1.6k 1.0×	782 0.5×	447 0.5×	380 0.5×	178	8.5k
María Lorenza Muiesan Italy	46	5.1k 0.7×	1.3k 0.8×	1.9k 1.2×	774 0.9×	319 0.4×	260	7.4k
Roberto Pedrinelli Italy	39	3.6k 0.5×	958 0.6×	1.8k 1.2×	660 0.8×	683 0.9×	255	7.1k

Countries citing papers authored by Carlo Porcellati

Since Specialization

Citations

This map shows the geographic impact of Carlo Porcellati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Porcellati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Porcellati more than expected).

Fields of papers citing papers by Carlo Porcellati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Porcellati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Porcellati. The network helps show where Carlo Porcellati may publish in the future.

Co-authorship network of co-authors of Carlo Porcellati

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Porcellati. A scholar is included among the top collaborators of Carlo Porcellati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Porcellati. Carlo Porcellati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amenta, Francesco, et al.. (2013). Observational study of hypertension and snoring in Northeastern Italy (Limana Hypertension Study). Clinical and Experimental Hypertension. 36(4). 263–267. 5 indexed citations

Schillaci, Giuseppe, Matteo Pirro, Tiziana Ronti, et al.. (2006). Prognostic Impact of Prolonged Ventricular Repolarization in Hypertension. Archives of Internal Medicine. 166(8). 909–909. 49 indexed citations

Verdecchia, Paolo, et al.. (2004). Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. Blood Pressure Monitoring. 9(4). 225–229. 21 indexed citations

Verdecchia, Paolo, Fabio Angeli, Roberto Gattobigio, et al.. (2004). Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?. Journal of Human Hypertension. 18(S2). S23–S28. 24 indexed citations

Verdecchia, Paolo, Gianpaolo Reboldi, Fabio Angeli, et al.. (2004). Prognostic value of lipoprotein fractions in essential hypertension. Blood Pressure. 13(5). 295–303. 6 indexed citations

Verdecchia, Paolo, Fabio Angeli, Roberto Gattobigio, & Carlo Porcellati. (2003). Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension. Expert Review of Cardiovascular Therapy. 1(1). 79–89. 6 indexed citations

Verdecchia, Paolo, Gianpaolo Reboldi, Carlo Porcellati, et al.. (2002). Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. Journal of the American College of Cardiology. 39(5). 878–885. 96 indexed citations

Schillaci, Giuseppe, Leonella Pasqualini, Paolo Verdecchia, et al.. (2002). Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. Journal of the American College of Cardiology. 39(12). 2005–2011. 218 indexed citations

Verdecchia, Paolo, Giuseppe Schillaci, Gianpaolo Reboldi, Giovanni de Simone, & Carlo Porcellati. (2001). Original articles prognostic value of combined echocardiography and ambulatory blood pressure monitoring in hypertensive patients at low or medium cardiovascular risk.. PubMed. 2(4). 287–93. 5 indexed citations

10.

Schillaci, Giuseppe, Paolo Verdecchia, Gianpaolo Reboldi, Sergio Pede, & Carlo Porcellati. (2000). Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure. The American Journal of Cardiology. 86(5). 509–513. 16 indexed citations

11.

Verdecchia, Paolo, Gianpaolo Reboldi, Giuseppe Schillaci, et al.. (1999). Value of a simple echocardiographic linear predictor of left ventricular mass in systemic hypertension. The American Journal of Cardiology. 84(10). 1209–1214. 4 indexed citations

12.

Verdecchia, Paolo, Giuseppe Schillaci, Claudia Borgioni, et al.. (1998). Prognostic Value of a New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension. Journal of the American College of Cardiology. 31(2). 383–390. 196 indexed citations

13.

Corea, L, et al.. (1996). Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine*. Clinical Pharmacology & Therapeutics. 60(3). 341–346. 124 indexed citations

14.

Verdecchia, Paolo, Giuseppe Schillaci, Claudia Borgioni, et al.. (1995). Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. Journal of the American College of Cardiology. 25(4). 871–878. 342 indexed citations

15.

Schillaci, Giuseppe, et al.. (1994). Non-invasive ambulatory BP monitoring during the night: randomised comparison of different reading intervals.. PubMed. 8(1). 23–7. 16 indexed citations

16.

Muiesan, M.L., Boni E. Elewski, Maurizio Castellano, et al.. (1993). Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris. European Heart Journal. 14(12). 1701–1708. 25 indexed citations

17.

Muiesan, María Lorenza, et al.. (1991). Efficacy of transdermal nitroglycerin in combination with an ACE-inhibitor in patients with chronic stable angina pectoris. Journal of the American College of Cardiology. 17(2). A377–A377. 11 indexed citations

18.

Verdecchia, Paolo & Carlo Porcellati. (1991). Association between decreased nocturnal blood pressure reduction and cardiac hypertrophy in hypertensive women. Journal of the American College of Cardiology. 17(2). A71–A71. 1 indexed citations

19.

Verdecchia, Paolo, et al.. (1988). Duration of the antihypertensive action of atenolol, enalapril and placebo: a randomized within-patient study using ambulatory blood pressure monitoring.. PubMed. 26(11). 570–4. 5 indexed citations

20.

Todisco, Tommaso, et al.. (1975). [Comparison of the bronchodilator action of fenoterol and salbutamol by aerosol administration in patients with bronchial asthma].. PubMed. 66(84). 4535–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact